Esophageal Squamous Cell Carcinoma Resectable
1 clinical trials · Condition
◉ Watch Esophageal Squamous Cell Carcinoma Resectable
| Record | Firm | Date |
|---|---|---|
| Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma (NCT01688700) | Zhejiang Cancer Hospital | 2012-09-01 |
Track Esophageal Squamous Cell Carcinoma Resectable automatically
Every clearance here is in the API, with alerts when new ones post.